Stock listing

BSE:DIVISLAB Divi's Laboratories Limited Share Price

Indian listing (BSE) of Divi's Laboratories Limited · home listing NSE:DIVISLAB

Follow Divi's Laboratories Limited into a list and get an email when it puts out news.

Home listing price · NSE:DIVISLAB

₹11,181 INR +132 (+1.2%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:DIVISLAB

Past year +73.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₹11,025 – ₹11,198 INRNov 20, 2026
Volume
404,820 sharesNov 20, 2026
Market cap
₹2.97T INRAt the close on Nov 20, 2026 · price × 265.5M shares outstanding
52-week range
₹5,647.50 – ₹11,824 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₹5.88B INRMedian day 531,107 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Divi's Laboratories Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NSE:DIVISLAB · Home₹11,181 INR+132 (+1.2%)404,820₹11,125₹11,198₹11,025₹11,049Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:DIVISLAB · INR, adjusted for splits

DayCloseChange%OpenHighLowVolume
₹11,181+132+1.2%₹11,125₹11,198₹11,025404,820
₹11,049-101-0.9%₹11,180₹11,265₹11,049472,664
₹11,150+70+0.6%₹11,087₹11,208₹11,030727,533
₹11,080-362-3.2%₹11,490₹11,545₹10,954903,606
₹11,442-43-0.4%₹11,412₹11,646₹11,351536,386
₹11,485+118+1.0%₹11,329₹11,485₹11,272728,927
₹11,367-199-1.7%₹11,760₹11,801₹11,1901,602,392
₹11,566+1,245+12.1%₹11,097₹11,824₹11,0712,586,198
₹10,321+180+1.8%₹10,130₹10,321₹10,041885,883
₹10,141+103+1.0%₹10,100₹10,159₹9,888.00837,076
₹10,038-27-0.3%₹10,060₹10,067₹9,946.00534,906
₹10,064+119+1.2%₹9,965.00₹10,064₹9,863.00611,299
₹9,945.50+166+1.7%₹9,900.00₹9,990.00₹9,868.00914,466
₹9,780.00+116+1.2%₹9,680.00₹9,865.00₹9,621.501,027,168
₹9,664.00+106+1.1%₹9,563.00₹9,685.50₹9,534.00395,170
₹9,558.50+53+0.6%₹9,460.00₹9,699.50₹9,370.00744,981
₹9,505.50+456+5.0%₹9,090.00₹9,505.50₹9,067.00802,563
₹9,050.00+100+1.1%₹8,900.00₹9,080.00₹8,860.00576,041
₹8,950.00-212-2.3%₹9,165.00₹9,175.50₹8,797.00620,239
₹9,162.00-28-0.3%₹9,114.00₹9,190.00₹9,006.501,040,584
₹9,190.00+103+1.1%₹9,190.00₹9,243.00₹9,041.00685,478
₹9,087.00-58-0.6%₹9,191.50₹9,323.50₹9,045.00448,972
₹9,144.50+115+1.3%₹9,030.50₹9,248.00₹8,985.50778,528
₹9,030.00+7+0.1%₹9,085.00₹9,124.50₹8,950.00645,244
₹9,023.00-262-2.8%₹9,315.00₹9,315.00₹8,937.50992,022
₹9,285.00-141-1.5%₹9,411.00₹9,423.50₹9,164.50416,650
₹9,426.00+86+0.9%₹9,346.00₹9,431.50₹9,297.00358,499
₹9,340.00-21-0.2%₹9,417.00₹9,460.50₹9,273.00378,861
₹9,361.00-227-2.4%₹9,588.00₹9,658.00₹9,355.00441,895
₹9,588.00+38+0.4%₹9,500.50₹9,660.00₹9,494.00422,217
₹9,550.00+354+3.8%₹9,210.00₹9,557.50₹9,165.00465,106
₹9,196.00-53-0.6%₹9,251.00₹9,285.50₹9,113.50480,338
₹9,249.0000.0%₹9,249.00₹9,249.00₹9,249.000
₹9,249.00-43-0.5%₹9,277.00₹9,318.00₹9,078.00567,310
₹9,291.50-140-1.5%₹9,499.50₹9,505.00₹9,275.00541,269
₹9,431.00-119-1.2%₹9,562.00₹9,610.50₹9,431.00652,089
₹9,550.00-70-0.7%₹9,600.00₹9,655.00₹9,473.00380,253
₹9,619.50+18+0.2%₹9,602.00₹9,668.50₹9,530.00388,859
₹9,602.00-22-0.2%₹9,540.50₹9,740.00₹9,540.00666,667
₹9,624.00+272+2.9%₹9,330.00₹9,624.00₹9,312.50489,382
₹9,352.00-59-0.6%₹9,444.00₹9,444.00₹9,315.50293,688
₹9,410.50+36+0.4%₹9,418.00₹9,461.50₹9,375.50380,343
₹9,375.00+52+0.6%₹9,346.50₹9,445.00₹9,328.50691,534
₹9,323.00+165+1.8%₹9,158.00₹9,371.00₹9,135.50494,167
₹9,158.00-40-0.4%₹9,168.00₹9,180.00₹8,923.00878,300
₹9,198.00-124-1.3%₹9,367.50₹9,397.50₹9,118.50380,826
₹9,322.0000.0%₹9,322.00₹9,322.00₹9,322.000
₹9,322.00-117-1.2%₹9,370.00₹9,415.00₹9,310.50516,756
₹9,438.50-50-0.5%₹9,600.50₹9,604.00₹9,386.50338,181
₹9,488.00-87-0.9%₹9,575.00₹9,615.00₹9,410.00385,273
₹9,575.00+260+2.8%₹9,375.50₹9,588.00₹9,253.00838,906
₹9,315.00+215+2.4%₹9,119.50₹9,315.00₹9,119.50502,162
₹9,100.00-150-1.6%₹9,244.00₹9,269.00₹9,100.00250,202
₹9,250.00+30+0.3%₹9,253.00₹9,282.00₹9,184.00497,269
₹9,220.00+55+0.6%₹9,121.50₹9,299.00₹9,104.50403,619
₹9,165.00-302-3.2%₹9,251.50₹9,262.50₹9,087.00485,620
₹9,467.00+228+2.5%₹9,239.00₹9,467.00₹9,140.00680,805
₹9,239.00+179+2.0%₹9,099.50₹9,270.00₹9,080.50773,225
₹9,060.00+35+0.4%₹9,045.00₹9,150.00₹9,035.00527,307
₹9,025.00+281+3.2%₹8,739.50₹9,043.00₹8,701.00708,128
₹8,744.50+249+2.9%₹8,500.00₹8,744.50₹8,497.00563,721
₹8,496.00-101-1.2%₹8,558.50₹8,563.50₹8,457.50251,013
₹8,597.00+27+0.3%₹8,600.00₹8,610.00₹8,505.50180,697
₹8,570.00+10+0.1%₹8,590.00₹8,597.50₹8,532.00198,190

Splits

3 splits since 2007 · NSE:DIVISLAB · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
2-for-1Split
5-for-1Split
Ticker
BSE:DIVISLAB
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
BSE
Currency
INR

Latest news

All Divi's Laboratories Limited news

Divi's Laboratories Limited on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
3 in all · newest Sep 26, 2023 · oldest 2023

Where Divi's Laboratories Limited is listed

ListingExchangeCountryCurrency
NSE:DIVISLAB · Home listingNSEIndiaINR
BSE:DIVISLAB · This pageBSEIndiaINR

Valuation

P/E 101× against a median of 33.8×: the highest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₹2.97T INR
P/E
101×
EV/sales
26.4×
EV/EBITDA
74.8×
Price/book
17.7×
Gross margin
49.9%
Operating margin
31.0%
Net margin
26.1%
Debt to equity
0.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Divi's Laboratories Limited · NSE:DIVISLABUS$32.03BUS$32.03B101×26.4×74.8×17.7×26.1%0.0×n/a
Sun Pharmaceutical Industries Limited · NSE:SUNPHARMAUS$48.81BUS$45.53B41.2×6.8×24.4×5.1×17.8%0.0×n/a
Teva Pharmaceutical Industries Limited · TASE:TEVAUS$46.34BUS$46.29B89.8×3.3×13.5×5.8×3.7%0.5×n/a
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A · SSE:600276US$45.00BUS$38.46B33.8×7.8×n/a4.5×27.0%0.0×n/a
Sandoz Group Ltd · SIX:SDZUS$41.49BUS$46.45B43.3×4.2×23.6×4.6×8.6%0.7×n/a
Celltrion, Inc. · KRX:068270US$36.08BUS$35.44B30.8×9.7×25.9×2.7×32.2%0.0×n/a
Zoetis Inc. · NYSE:ZTSUS$32.69BUS$40.21B13.0×4.2×10.2×9.9×26.4%2.7×0.69
Hansoh Pharmaceutical Group Company Limited · HKEX:3692US$23.78BUS$18.80B28.5×8.3×21.6×4.2×37.0%0.1×n/a
United Therapeutics Corporation · NASDAQ:UTHRUS$23.63BUS$21.56B19.2×6.8×15.2×3.8×38.6%0.0×0.46
Incyte Corporation · NASDAQ:INCYUS$23.36BUS$20.09B57.9×3.3×n/a4.1×6.7%0.0×0.48
Viatris Inc. · NASDAQ:VTRSUS$22.50BUS$33.92Bn/a2.3×12.1×1.6×−4.1%1.0×0.65
Median of the othersUS$34.39BUS$36.95B33.8×5.5×18.4×4.3×22.1%0.1×0.56

Forecasts

Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
8693.46 INR · Analysts' mean
EPS, year to Mar 2027
127.16 · 27 analysts
Revenue, year to Mar 2027
127.6B · 27 analysts

Team and board

Officers

OfficerRole
Kiran S. DiviWhole-Time Director & Chief Executive Officer
Murali K. DiviManaging Director

Board

DirectorRole
Ramesh B.V. NimmagaddaNon-Executive Chairman & Independent Director
Rajendra Kumar PremchandIndependent Director
Sunaina SinghIndependent Director

Events

Next results
Feb 6, 2027 (expected)
QuarterResultsShare move
Quarter to Sep 30, 2026Nov 7, 2026 · Before open+12.1%
Q1 2027Aug 1, 2026 · Before open+6.6%
Q4 2026May 23, 2026 · Before open−1.9%
Q3 2026Feb 11, 2026 · Before open+3.4%
Q2 2026Nov 7, 2025 · Before open−3.3%
Q1 2026Aug 6, 2025 · Before open−4.3%
Q4 2025May 17, 2025 · Before open+4.8%
Q3 2025Feb 3, 2025 · Before open+4.7%
Q2 2025Nov 9, 2024 · Before open−0.8%
Q1 2025Aug 3, 2024 · Before open−3.3%
All 20 quarters
QuarterResultsShare move
Q4 2024May 25, 2024 · Before open+3.2%
Q3 2024Feb 10, 2024 · Before open+2.4%
Q2 2024Nov 6, 2023 · Before open+4.7%
Q1 2024Aug 14, 2023 · Before open+1.4%
Q4 2023May 20, 2023 · Before open+5.4%
Q3 2023Feb 3, 2023 · Before open−11.7%
Q2 2023Nov 7, 2022 · Before open−8.9%
Q1 2023Aug 12, 2022 · Before open−5.6%
Q4 2022May 23, 2022 · Before open−9.4%
Q3 2022Feb 11, 2022 · Before open−0.5%

Open Events

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue105.6B93.3B78.0B76.7B88.0B68.6B52.9B48.0B38.1B40.5B
Cost of revenue60.0B38.7B32.7B31.8B30.9B24.3B5.59B1.96B4.79B2.38B
Gross profit45.6B54.5B45.3B44.9B57.1B44.3B47.3B46.1B33.3B38.2B
Research and development400.0M270.0M350.0M300.0M202.9M149.7M111.4M106.0M101.1M119.5M
Selling, general and administrative3.16B1.43B1.25B1.26B1.09B831.4M746.9M542.3M905.3M428.1M
Operating income29.8B25.7B18.3B20.3B35.7B26.2B16.4B17.1B11.3B13.6B
Depreciation and amortization4.63B4.02B3.78B3.43B3.12B2.56B1.86B1.69B1.42B1.23B
EBITDA34.4B29.7B22.1B23.7B38.9B28.7B18.3B18.8B12.7B14.9B
Interest expense230.0M30.0M30.0M19.6M19.9M20.9M71.3M28.5M23.5M21.7M
Income before tax33.9B29.2B21.6B23.7B36.8B26.7B18.2B18.6B12.3B14.0B
Income tax8.20B7.25B5.63B5.45B7.23B6.82B4.43B5.02B3.54B3.35B
Net income25.7B21.9B16.0B18.2B29.6B19.8B13.8B13.5B8.77B10.6B
Earnings per share, basic96.7582.5360.2768.71111.5274.7551.8550.9633.0439.95

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents1.28B4.32B3.63B1.70B12.1B20.3B431.5M130.0M251.5M207.9M
Short-term investments31.1B31.2B33.4B39.7B15.3B546.4M110.1M14.0B18.9B16.3B
Receivables31.1B29.8B21.6B17.9B24.3B16.2B14.5B585.4M433.8M9.39B
Inventory39.5B33.2B31.8B30.0B28.3B21.5B18.6B17.7B13.5B13.6B
Current assets111.0B100.8B96.8B93.1B83.5B61.7B46.8B46.5B45.4B40.1B
Property, plant and equipment64.6B55.1B49.3B47.9B44.1B37.0B25.8B21.1B20.0B
Total assets200.3B169.5B154.7B144.4B133.7B107.7B85.4B80.4B67.9B61.6B
Accounts payable12.1B9.10B8.24B7.62B7.96B7.63B5.91B4.92B4.11B4.46B
Current liabilities20.4B14.5B12.8B11.0B12.0B11.1B9.27B8.47B6.53B6.59B
Total debt70.0M40.0M30.0M44.9M36.9M48.3M388.5M1.06B631.1M357.4M
Total liabilities32.7B19.8B19.0B16.7B16.5B14.8B12.3B10.8B8.61B8.01B
Shareholders' equity167.6B149.7B135.7B127.7B117.3B92.9B73.1B69.6B59.2B53.6B
Shares outstanding265.4M265.5M265.5M265.5M265.5M265.5M265.5M265.5M265.5M265.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations30.2B19.5B12.6B24.6B19.1B19.5B12.2B9.54B7.76B11.5B
Capital spending-25.2B-14.4B-10.0B-4.73B-7.13B-9.10B-11.8B-7.33B-2.74B-3.77B
Free cash flow4.97B5.08B2.58B19.9B12.0B10.4B327.3M2.21B5.02B7.74B
Cash from investing-25.0B-11.0B-2.69B-27.1B-21.9B751.3M-834.7M-6.85B-4.78B-11.4B
Cash from financing-7.99B-7.97B-7.99B-7.97B-5.32B-348.9M-10.9B-2.46B-3.14B23.8M
Dividends paid-7.97B-7.96B-7.96B-7.96B-5.31B-5.31B-10.2B-3.20B-3.19B-3.19B
Change in cash29.8B610.0M1.93B-10.5B-8.16B19.9B410.5M229.6M-166.0M-222.1M

Open Financials

Filings

FilingDateTypeFiled with
Press Release (Revised) Sep 26 2023Sep 26, 2023Other filingsNSE India
Press Release Sep 26 2023Sep 26, 2023Other filingsNSE India
Press Release May 20 2023May 20, 2023ResultsNSE India

Open Filings

Cap table

Built by 6ix from Divi's Laboratories Limited’s releases

Common shares
265,468,580
Fully diluted
265,468,580

Fully diluted

LineShares
Common shares265,468,580

Share count over time

CountShares
Nov 22, 2026265,468,580

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund1.88MUS$159MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund1.78MUS$151MJul 31, 2026
iShares Core MSCI Emerging Markets ETF1.32MUS$92.7MMay 31, 2026
Fidelity Series Emerging Markets Opportunities Fund604KUS$51MJul 31, 2026
iShares MSCI India ETF580KUS$40.7MMay 31, 2026
Fidelity SAI Emerging Markets Value Index Fund576KUS$48.6MJul 31, 2026
T. Rowe Price Emerging Markets Stock Fund479KUS$40.4MJul 31, 2026
Baron Emerging Markets Fund430KUS$29.9MJun 30, 2026
T. Rowe Price New Asia Fund300KUS$25.3MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund299KUS$25.3MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
iShares MSCI Emerging Markets ex China ETF291KUS$20.4MMay 31, 2026
iShares MSCI Emerging Markets ETF286KUS$20MMay 31, 2026
Fidelity Series Global ex U.S. Index Fund238KUS$20.1MJul 31, 2026
Franklin FTSE India ETF207KUS$14.4MJun 30, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF205KUS$14.3MJun 30, 2026
Emerging Markets Core Equity 2 Portfolio174KUS$14.8MJul 31, 2026
Wasatch Emerging India Fund170KUS$11.8MJun 30, 2026
iShares Core MSCI Total International Stock ETF166KUS$14MJul 31, 2026
Schwab Emerging Markets Equity ETF154KUS$10.8MMay 31, 2026
Fidelity Emerging Markets Index Fund147KUS$12.4MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account114KUS$7.96MJun 30, 2026
Wasatch Emerging Markets Select Fund110KUS$7.66MJun 30, 2026
iShares MSCI Emerging Markets Min Vol Factor ETF108KUS$7.54MMay 31, 2026
Vanguard Total World Stock Index Fund105KUS$8.86MJul 31, 2026
WisdomTree India Earnings Fund103KUS$7.17MJun 30, 2026
Nuveen Emerging Markets Equity Index Fund94,140US$7.95MJul 31, 2026
Fidelity Total International Index Fund69,592US$5.88MJul 31, 2026
The Emerging Markets Series68,881US$5.84MJul 31, 2026
Dimensional Emerging Core Equity Market ETF66,502US$5.61MJul 31, 2026
Fidelity Emerging Markets Equity Central Fund65,356US$4.55MJun 30, 2026
Fidelity Global ex U.S. Index Fund63,585US$5.37MJul 31, 2026
Avantis Emerging Markets Equity ETF59,268US$4.16MMay 31, 2026
Matthews India Fund47,979US$3.34MJun 30, 2026
iShares MSCI ACWI ETF44,792US$3.78MJul 31, 2026
Wasatch Global Opportunities Fund44,305US$3.08MJun 30, 2026
T. Rowe Price Institutional Emerging Markets Equity Fund43,982US$3.71MJul 31, 2026
iShares MSCI All Country Asia ex Japan ETF40,338US$3.41MJul 31, 2026
Greater India Portfolio38,981US$2.71MJun 30, 2026
Columbia EM Core ex-China ETF37,676US$2.62MJun 30, 2026
iShares MSCI ACWI ex U.S. ETF36,831US$3.11MJul 31, 2026
Fidelity SAI Emerging Markets Index Fund36,110US$3.05MJul 31, 2026
Tax-Managed International Equity Fund31,738US$2.68MJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio31,164US$2.17MJun 30, 2026
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund31,159US$2.17MJun 30, 2026
Dimensional Emerging Markets Core Equity 2 ETF28,182US$2.38MJul 31, 2026
Emerging Markets Equity Index Fund27,970US$1.95MJun 30, 2026
Emerging Markets Leaders Portfolio27,202US$1.89MJun 30, 2026
Vanguard ESG International Stock ETF25,694US$1.8MMay 31, 2026
iShares MSCI Global Min Vol Factor ETF24,767US$1.74MMay 31, 2026
Goldman Sachs India Equity ETF24,480US$1.72MMay 31, 2026

This page holds 50 of 117 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kiran S. DiviWhole-Time Director & Chief Executive Officer · Since at least Nov 6, 2026
Murali K. DiviManaging Director · Since at least Nov 6, 2026
Rajendra Kumar PremchandIndependent Director · Since at least Nov 6, 2026
Ramesh B.V. NimmagaddaNon-Executive Chairman & Independent Director · Since at least Nov 6, 2026
Sunaina SinghIndependent Director · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Divi's Laboratories Limited.